{"id": "1338506582657818625", "creation": 1607959812.0, "user_id": "1247376635004936192", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "CureVac Commences Global Pivotal Phase 2b/3 Trial for its mRNA #COVID19 #Vaccine Candidate, CVnCoV\n\nThe study is expected to include more than 35,000 participants at sites in Europe and Latin America.\nhttps://t.co/THUMiytqXd", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE"]}